Immunologie nieuws
- U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B
- [Obituary] Tobias Welte
- [Comment] Carbapenem use in US hospitals: guidance and stewardship
- [Comment] Lessons for dengue vaccines from a human challenge study
- [Articles] Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial
- [Articles] Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study
- Pushing boundaries: mechanisms enabling bacterial pathogens to spread between cells
- Commissiedebat Zoönosen en dierziekten op 29 mei 2024
- MICROBIOME and INFECTIOUS DISEASE: DIAGNOSTICS to THERAPEUTICS
- Effects of different immunomodulating liposome-based adjuvants and injection sites on immunogenicity in pigs
- Hemozoin-induced IFN-? production mediates innate immune protection against sporozoite infection
- Effects of individual and environmental factors on COVID-19 infection control practices in small to medium-sized hospitals
- Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study
- Cow's milk oral immunotherapy has differentially better long-term adherence than peanut or sesame
- [Corrections] Correction to Lancet Infect Dis 2024; published online Jan 17. https://doi.org/10.1016/S1473-3099(24)00032-X